Dr. Rola A. Mahmoud, MD

Dr. Mahmoud practices at Kansas City Physician Partners Inc in Kansas City, Missouri.

Dr. Mahmoud's NPI, 1114207370, was assigned on August 19, 2011. Dr. Mahmoud holds Missouri license 2016027117.

Dr. Mahmoud's primary practice is Kansas City Physician Partners Inc, at 4440 Broadway Blvd, Kansas City, MO 64111 in Jackson County. The practice phone is (816) 531-0930.

Dr. Mahmoud's primary practice is Kansas City Physician Partners Inc in Kansas City, Missouri. Dr. Mahmoud is also affiliated with Saint Luke's Hospital of Kansas City. The medical group on file is Select Physical Therapy. Dmand AI also links Dr. Mahmoud to 4 more hospitals, 2 group practices and clinics, 2 medical groups and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mahmoud practices, 8 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Mahmoud's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Mahmoud's licenses on file in 2 states: Missouri and Kansas.

CMS data shows 777 Medicare services from Dr. Mahmoud across 14 procedure codes in 2024, for 127 Medicare patients. Medicare paid $37,677 for them. Every service was in an office.

CMS counts 127 Medicare patients who saw Dr. Mahmoud in 2024. The largest group is 65 to 74, with 54 patients. 66% of them have high cholesterol, and 57% have arthritis. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mahmoud's median patient age at 55, with 75% women.

In 2024, Dr. Mahmoud wrote 784 Medicare Part D claims for 115 patients. 86% of them were for generic drugs. CMS names the drug for 550 of them, across 24 drugs with 11 or more claims each, at $494,732 in total drug cost. In 2023, CMS named 962 claims across 37 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Mahmoud for performance year 2024, reported through an alternative payment model (APM). Dr. Mahmoud accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mahmoud as offering telehealth.

Dmand AI links 9 papers to Dr. Mahmoud, published from 2012 to 2024. 2023 was the busiest year, with 3. The most frequent topics are Multiple Sclerosis, Obesity and Arginine. Dr. Mahmoud has published most often in BMJ Case Rep. Dr. Mahmoud's most frequent co-authors are Betty M. Drees, MD, Salim Chahin, MD and Sean Matthew Gratton, MD.

CMS Open Payments shows 240 general payments to Dr. Mahmoud from 21 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 70% of the total. EMD Serono, Inc. paid the most, $70,636.